| Product Code: ETC10223170 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Belgium continued to see significant import shipments of prostate-specific antigen blood-based biomarkers, with top exporting countries being the USA, Austria, Netherlands, Hungary, and the UK. Despite the high Herfindahl-Hirschman Index (HHI) indicating market concentration, the compound annual growth rate (CAGR) from 2020 to 2024 was an impressive 39.8%. However, there was a notable decline in growth rate from 2023 to 2024 at -59.2%, suggesting potential market fluctuations or regulatory changes impacting the industry.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market Overview |
3.1 Belgium Country Macro Economic Indicators |
3.2 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, 2021 & 2031F |
3.3 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market - Industry Life Cycle |
3.4 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market - Porter's Five Forces |
3.5 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume Share, By Test Sensitivity, 2021 & 2031F |
3.8 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume Share, By End Use, 2021 & 2031F |
3.9 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume Share, By Distribution, 2021 & 2031F |
4 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of prostate cancer in Belgium |
4.2.2 Growing awareness about the importance of early detection and screening for prostate cancer |
4.2.3 Technological advancements in diagnostic testing for prostate-specific antigen (PSA) |
4.3 Market Restraints |
4.3.1 Regulatory challenges and stringent approval processes for new biomarker tests |
4.3.2 Concerns about overdiagnosis and overtreatment of prostate cancer |
4.3.3 Competition from alternative diagnostic methods for prostate cancer detection |
5 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market Trends |
6 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market, By Types |
6.1 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Application, 2021 - 2031F |
6.1.3 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Diagnostic Testing, 2021 - 2031F |
6.1.4 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Screening, 2021 - 2031F |
6.1.5 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Prognostic Testing, 2021 - 2031F |
6.1.6 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Monitoring, 2021 - 2031F |
6.2 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Serum PSA, 2021 - 2031F |
6.2.3 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Free PSA, 2021 - 2031F |
6.2.4 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Total PSA, 2021 - 2031F |
6.2.5 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Complex PSA, 2021 - 2031F |
6.3 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market, By Test Sensitivity |
6.3.1 Overview and Analysis |
6.3.2 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By High Sensitivity, 2021 - 2031F |
6.3.3 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Low Sensitivity, 2021 - 2031F |
6.3.4 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Specificity, 2021 - 2031F |
6.4 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market, By End Use |
6.4.1 Overview and Analysis |
6.4.2 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4.4 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Diagnostic Centers, 2021 - 2031F |
6.5 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market, By Distribution |
6.5.1 Overview and Analysis |
6.5.2 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Direct-to-Consumer, 2021 - 2031F |
6.5.3 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Pharmacies, 2021 - 2031F |
6.5.4 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, By Hospitals, 2021 - 2031F |
7 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market Import-Export Trade Statistics |
7.1 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market Export to Major Countries |
7.2 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market Imports from Major Countries |
8 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market Key Performance Indicators |
8.1 Average age of prostate cancer diagnosis in Belgium |
8.2 Percentage of men undergoing regular PSA screening in Belgium |
8.3 Adoption rate of new PSA biomarker tests in clinical practice |
9 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market - Opportunity Assessment |
9.1 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market Opportunity Assessment, By Test Sensitivity, 2021 & 2031F |
9.4 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market Opportunity Assessment, By End Use, 2021 & 2031F |
9.5 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market Opportunity Assessment, By Distribution, 2021 & 2031F |
10 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market - Competitive Landscape |
10.1 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market Revenue Share, By Companies, 2024 |
10.2 Belgium Prostate-Specific Antigen Blood-Based Biomarker Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here